151 related articles for article (PubMed ID: 32577941)
21. Medication Safety in Intravenous Therapy: A Compatibility Study of Clonidine with Drugs Frequently Used in Intensive Care.
Koller AK; Krebs S; Dörje F
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374362
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of solutions for the storage of granulocyte colony-stimulating factor-mobilized granulocyte concentrates.
Lightfoot T; Gallelli J; Matsuo K; Kwon SW; Leitman SF; Stroncek DF
Vox Sang; 2001 Feb; 80(2):106-11. PubMed ID: 11378965
[TBL] [Abstract][Full Text] [Related]
23. Validation of RP-HPLC method to assess the compatibility of metoclopramide and midazolam intravenous mixture used in patients with cancer.
Sanogo S; Silimbani P; Gaggeri R; Rossi R; Elviri L; Maltoni M; Masini C
Eur J Hosp Pharm; 2019 Nov; 26(6):323-328. PubMed ID: 31798855
[TBL] [Abstract][Full Text] [Related]
24. Acid-base effects of a bicarbonate-balanced priming fluid during cardiopulmonary bypass: comparison with Plasma-Lyte 148. A randomised single-blinded study.
Morgan TJ; Power G; Venkatesh B; Jones MA
Anaesth Intensive Care; 2008 Nov; 36(6):822-9. PubMed ID: 19115651
[TBL] [Abstract][Full Text] [Related]
25. Plasma-Lyte 148: A clinical review.
Weinberg L; Collins N; Van Mourik K; Tan C; Bellomo R
World J Crit Care Med; 2016 Nov; 5(4):235-250. PubMed ID: 27896148
[TBL] [Abstract][Full Text] [Related]
26. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
[TBL] [Abstract][Full Text] [Related]
27. Y-site simulation compatibility study of 10% calcium salts with various injectable solutions during toxicological resuscitation.
Hamelin A; Thompson-Desormeaux F; Elliott A; Friciu M; Forest JM; Leclair G
Eur J Hosp Pharm; 2023 Jul; ():. PubMed ID: 37438091
[TBL] [Abstract][Full Text] [Related]
28. Compatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride and nitroprusside.
Schaaf LJ; Tremel LC; Wulf BG; Vernon KK
J Clin Pharm Ther; 1990 Oct; 15(5):371-6. PubMed ID: 1963175
[TBL] [Abstract][Full Text] [Related]
29. [Physical compatibility of furosemide in intravenous mixtures for continuous perfusion].
Pérez Juan E; Maqueda Palau M; Arévalo Rubert M; Ribas Nicolau B; Amorós Cerdá SM
Enferm Intensiva; 2010; 21(3):96-103. PubMed ID: 20413337
[TBL] [Abstract][Full Text] [Related]
30. Sodium reduction during cardiopulmonary bypass: Plasma-Lyte 148 versus trial fluid as pump primes.
Morgan TJ; Presneill JJ; Davies PG; Power G; Venkatesh B
Crit Care Resusc; 2015 Dec; 17(4):263-7. PubMed ID: 26640062
[TBL] [Abstract][Full Text] [Related]
31. Compatibility of furosemide with aminoglycoside admixtures.
Thompson DF; Allen LV; Desai SR; Rao PS
Am J Hosp Pharm; 1985 Jan; 42(1):116-9. PubMed ID: 3970026
[TBL] [Abstract][Full Text] [Related]
32. Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administration.
Mann HJ; Demmon SL; Boelk DA; Payne CA; Effron MB; Rajagopalan N; Williams MD; Beck GM; Gopalrathnam G
Am J Health Syst Pharm; 2004 Dec; 61(24):2664-71. PubMed ID: 15646701
[TBL] [Abstract][Full Text] [Related]
33. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.
Kambia NK; Luyckx M; Dine T; Dupin-Spriet T; Gressier B; Brunet C
J Clin Pharm Ther; 2009 Feb; 34(1):25-31. PubMed ID: 19125900
[TBL] [Abstract][Full Text] [Related]
34. Stability and compatibility of doxofylline with phentolamine mesilate in 0.9% sodium chloride or 5% dextrose injection for intravenous infusion.
Xu F; Xu G; Su L; Feng E
J Clin Pharm Ther; 2011 Feb; 36(1):99-102. PubMed ID: 21198724
[TBL] [Abstract][Full Text] [Related]
35. Physicochemical compatibility of nebulizable drug admixtures containing budesonide and colistimethate or hypertonic saline.
Klemmer A; Krämer I; Kamin W
Int J Pharm Compd; 2013; 17(3):254-61. PubMed ID: 24046941
[TBL] [Abstract][Full Text] [Related]
36. Compatibility of heparin sodium and morphine sulfate.
Baker DE; Yost GS; Craig VL; Campbell RK
Am J Hosp Pharm; 1985 Jun; 42(6):1352-5. PubMed ID: 4014252
[TBL] [Abstract][Full Text] [Related]
37. Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.
Johnson CE; Cohen IA; Craft DA; Lizer MH
Am J Hosp Pharm; 1986 Jun; 43(6):1482-5. PubMed ID: 3524206
[TBL] [Abstract][Full Text] [Related]
38. Intropin (dopamine hydrochloride) intravenous admixture compatibility, Part 3: stability with miscellaneous additives.
Gardella LA; Kesler H; Amann A; Carter JE
Am J Hosp Pharm; 1978 May; 35(5):581-4. PubMed ID: 655182
[TBL] [Abstract][Full Text] [Related]
39. Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 1: stability with common intravenous fluids.
Gardella LA; Zaroslinski JF; Possley LH
Am J Hosp Pharm; 1975 Jun; 32(6):575-8. PubMed ID: 239594
[TBL] [Abstract][Full Text] [Related]
40. Stability of admixtures of pethidine and metoclopramide in aqueous solution, 5% dextrose and 09% sodium chloride.
Hor MM; Chan SY; Yow KL; Lim LY; Chan E
J Clin Pharm Ther; 1997; 22(5-6):339-45. PubMed ID: 19160718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
